Last Price$177.71.5%
Market Cap$77.8B
5.9%
Peers median - 8.1%
25.5%
Peers median - 6.9%
25.4%
Peers median - 68.4%
18.2%
Peers median - 6.2%
Competing with TRI
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$77.8B | 6.4 | $106.8 39.9% overvalued | 14.6% | $7,249.2M | $1,849.3M | 5.9% | 25.5% | 32.8% | 18.2% | 25.4% | |
$82.8B | 7.6 | $64.3 68.3% overvalued | 30.0% | $9,940.5M | $1,855.0M | 8.1% | 18.7% | 48.8% | 27.1% | 66.3% | |
$25.3B | 7.3 | $160.1 58.9% undervalued | (21.2%) | $10.1B | $2,857.8M | 4.7% | 28.3% | 72.2% | 5.6% | 70.6% | |
$18.7B | 7.7 | $80.8 20.3% overvalued | 35.1% | $4,279.2M | $1,001.4M | 15.4% | 23.4% | 56.3% | 5.9% | 73.4% | |
$11.6B | 6.6 | $63.8 178.0% undervalued | (28.5%) | £10.2B | £988.6M | 68.9% | 9.7% | 14.0% | 13.9% | 116.6% | |
$9,517.2M | 5.2 | $42.7 18.7% undervalued | 14.5% | $17.5B | $484.6M | (6.0%) | 2.8% | 7.1% | 6.4% | 40.2% | |
$4,251.8M | 5.7 | $128.9 81.1% undervalued | (16.0%) | $5,381.8M | $280.7M | 8.0% | 5.2% | 22.9% | 11.2% | 5.4% | |
$3,894.3M | 5.8 | $155.8 25.6% overvalued | 25.0% | $2,438.7M | $186.4M | 6.7% | 7.6% | 30.8% | 6.7% | 3.2% | |
$3,805.0M | 5.2 | $65.6 9.7% overvalued | (4.6%) | $1,813.5M | $110.8M | 14.0% | 6.1% | 10.1% | 2.5% | 103.0% | |
$3,453.2M | 5.3 | $139.8 155.8% undervalued | 28.5% | $8,359.3M | $167.2M | 3.2% | 2.0% | 34.8% | 3.7% | 81.5% | |
$2,171.4M | 5.2 | $1,369.0 10,162.2% undervalued | (17.0%) | $307.7B | $16.3M | 40,184.5% | 0.0% | 99.9% | (4.1%) | 2.2% |
Compare TRI Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
Thomson Reuters CorporationTRI
10.9x
2.5%
49.0%
39.7%
Median Peer Set
1.4x
8.4%
21.2%
5.9%
ABM Industries IncorporatedABM
0.6x
3.2%
(66.1%)
1.0%
AramarkARMK
0.6x
(7.7%)
(61.4%)
1.5%
CBIZ, Inc.CBZ
3.1x
14.0%
(67.8%)
2.3%
Cintas CorporationCTAS
8.6x
8.9%
16.7%
16.4%
First Advantage CorporationFA
(0.4x)
(5.7%)
(39.5%)
4.9%
Global Payments Inc.GPN
3.9x
4.7%
63.5%
15.5%
Maximus, Inc.MMS
0.8x
8.2%
89.8%
5.8%
RB Global, Inc.RBA
5.2x
16.4%
114.3%
9.6%
Rentokil Initial plcRTO
1.2x
45.5%
25.6%
7.1%
UniFirst CorporationUNF
1.6x
8.7%
35.0%
6.0%
Compare TRI Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Thomson Reuters Corporation (TRI) revenue growth compare to peers and the industry?
Thomson Reuters Corporation (TRI) revenue growth is 5.9%, compared to the peers' median of 8.1%.
2. How does Thomson Reuters Corporation (TRI) Free Cash Flow (FCF) margin compare to peers and the industry?
Thomson Reuters Corporation (TRI) FCF margin is 25.5%, compared to the peers' median of 6.9%.
3. How does Thomson Reuters Corporation (TRI) Total Debt to Equity ratio compare to peers and the industry?
Thomson Reuters Corporation (TRI) Total Debt to Equity ratio is 25.4%, compared to the peers' median of 68.4%.
4. How does Thomson Reuters Corporation (TRI) ROIC (Return on Invested Capital) compare to peers and the industry?
Thomson Reuters Corporation (TRI) ROIC is 18.2%, compared to the peers' median of 6.2%.